β-Trace protein in cerebrospinal fluid: A blood-CSF barrier-related evaluation in neurological diseases

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 882-889

  Tumani, Hayrettin ^a   Nau, Roland ^a   Felgenhauer, Klaus ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; VERTEBRAL CANAL STENOSIS; VIRUS MENINGITIS;

EID: 0031768283     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440606     Document Type: Article

References (33)

1. Felgenhauer K, Schliep G, Rapic N. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci 1976; 30:113-128
2. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987;163:319-328
3. Felgenhauer K. Protein filtration and secretion at human body fluid barriers. Pflugers Arch 1980;384:9-17
4. Reiber H. Flow rate of cerebrospinal fluid (CSF): a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994;122:189-203
5. Hochwald GM, Pepe AJ, Thorbecke GJ. Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of gamma-trace and beta-trace proteins. Proc Soc Exp Med 1967;124:961-966
6. Penny R, Osserman EF. Studies on beta-trace protein. Aust J Exp Biol Med Sci 1971;49:111-120
7. Link H, Olsson JE. Beta-trace protein concentration in CSF in neurological disorders. Acta Neurol Scand 1972;48:57-68
8. Hoffman A, Conradt HS, Gross G, et al. Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem 1993;61:451-456
9. Watanabe K, Urade Y, Mäder M, et al. Identification of beta-trace as prostaglandin D synthase. Biochem Biophys Res Commun 1994;203:1110-1116
10. Zahn M, Mäder M, Schmidt B, et al. Purification and N-terminal sequence of beta-trace, a protein abundant in human cerebrospinal fluid. Neurosci Lett 1993;154:93-95
11. Hayaishi O, Matsumura H, Urade Y. Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep. J Lipid Mediat 1993;6:429-431
12. Urade Y, Tanaka T, Eguchi N, et al. Structural and functional significance of cysteine residues of glutathione-independent prostaglandin D synthase. Identification of Cys65 as an essential thiol. J Biol Chem 1995;270:1422-1428
13. Hoffman A, Bachner D, Betat N, et al. Developmental expression of murine beta-trace in embryos and adult animal suggest a function in maturation and maintenance of blood-tissue barriers. Dev Dyn 1996;207:332-343
14. Olsson JE, Blomstrand C, Haglid KG. Cellular distribution of beta-trace protein in CNS and brain tumours. J Neurol Neurosurg Psychiatry 1974;37:302-311
15. Urade Y, Kitahama K, Ohishi H, et al. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 1993;90:9070-9074
16. Blödorn B, Mäder M, Urade Y, et al. Choroid plexus: the ma-jor site of mRNA expression for the beta-ttace protein (prostaglandin D synthase) in human brain. Neurosci Lett 1996;209: 117-120
17. Yamashima T, Sakuda K, Tohma Y, et al. Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J Neurosci 1997;17: 2376-2382
18. Tumani H, Reiber H. Influence of CSF flow rate on β-trace protein concentrations in ventricular and lumbar CSF. Locus of biosynthesis and influences of neurological disorders. J Mol Med 1997;75:B99 (Abstract)
19. Felgenhauer K, Schädlich HJ, Nekic M. Beta trace-ptotein as marker for cerebrospinal fluid fistula. Klin Wochenschr 1987; 65:764-768
20. Melegos DN, Freedman MS, Diamandis EP. Prostaglandin D synthase concenttation in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 1997;54: 463-474
21. Tumani H, Reiber H, Nau R, et al. Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis. Neurosci Lett 1998;242:5-8
22. Felgenhauer K. The filtration concept of the blood-CSF barrier as basis for the differentiation of CSF proteins. In: Greenwood J, Begley DJ, Segal MB, eds. New concepts of a blood-brain barrier. New York: Plenum Press, 1995:209-217
23. 125I-labelled β-trace protein, with special reference to synthesis within the central nervous system. J Neurochem 1973;21: 1153-1159
24. May C, Kaye JA, Atack JR, et al. Cerebrospinal fluid production is reduced in healthy aging. Neurology 1990;40:500-503
25. Vesin MF, Urade Y, Hayaishi O, Droz B. Neuronal and glial prostaglandin D synthase isozymes in chick dorsal root ganglia: a light and electron microscopic immunocytochemical study. J Neurosci 1995;15:470-476
26. Tourtellotte WW, Ma BJ. Multiple sclerosis: the blood-brain-barrier and the measurement of the de novo central nervous system IgG synthesis. Neurology 1978;28:76-83
27. Link H, Tibbling G. Principles of albimin and IgG disorders. Evaluation ot IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977;37:397-401
28. Laurell CB. On the origin of major CSF proteins. In: Thompson E, ed. Advances in CSF protein research and diagnosis. London: MTP Press, 1987:123-128
29. Lewczuk P, Reiber H, Tumani H. Intercellular adhesion molecule-1 (slCAM-1) in cerebrospinal fluid - the evaluation of blood-derived and brain derived fractions in neurological diseases. J Neuroimmunol 1998;87:156-161
30. Ling EW, Noya FJ, Ricard G, et al. Biochemical mediators of meningeal inflammatory response to group B streptococcus in the newborn piglet model. Pediatr Res 1995;38:981-987
31. Mustafa MM, Ramilo O, Saez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin I beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990;144:883-887
32. Hyman S, McComb G, Megerdichian L, Weiss MH. Blood-cerebrospinal fluid barrier alteration following intraventricularly administered cholera toxin. Brain Res 1987;419:104-111
33. Quagliarello VJ, Ma A, Stukenbrok H, Palade GE. Ultrastructural localization ot albumin transport across the cerebral microvasculature during experimental meningitis in the rat. J Exp Med 1991;174:657-672